RxDoctor Payments Data

Erica Cress, PA

Medical · Harrisville, PANPI 1205262250

Payments from drug & device makers

$10,274in general payments, 2019–2025

Across 610 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AbbVie$1K
  • Novo Nordisk$1K
  • GSK$1K
  • Pfizer$683
  • AstraZeneca$645
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$10,16999%
  • Education$1051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,274 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$7,044
Medicare patients
41
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide27$45,449
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$40,485
TrulicityDulaglutide19$25,565
JardianceEmpagliflozin32$24,796
OzempicSemaglutide15$23,823
LinzessLinaclotide18$12,744
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,501
MyrbetriqMirabegron14$6,094
Arnuity ElliptaFluticasone Furoate12$2,444
Albuterol Sulfate HfaAlbuterol Sulfate55$1,469
Ventolin HfaAlbuterol Sulfate13$913
Lisinopril112$900
Atorvastatin Calcium90$884
Levothyroxine Sodium116$866
Rosuvastatin Calcium66$803

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,269$71,01446 claims
GSKTrelegy Ellipta, Arnuity Ellipta$1,107$42,92859 claims
Boehringer IngelheimJardiance$330$24,79632 claims
Novo NordiskOzempic$1,120$23,82315 claims
AbbVieLinzess$1,195$12,74418 claims
AstraZenecaBreztri Aerosphere$645$11,50113 claims
Astellas Pharma US IncMyrbetriq$254$6,09414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Harrisville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →